Jove
Visualize
お問い合わせ

関連する概念動画

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

13.9K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.9K
Blood Transfusion01:15

Blood Transfusion

2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A CBC drawn postnatally from umbilical cord blood can provide valuable diagnostic information for infants admitted to the NICU.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Tumor-Associated Platelets Suppress T-Cell Function and Promote Immune Evasion in TNBC via the P-selectin/ P-selectin glycoprotein ligand-1 Pathway.

Cancer research communications·2026
Same author

Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.

Frontiers in immunology·2026
Same author

Cryoprecipitate utilization in the neonatal intensive care unit: a single-center review.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

R213G-Mediated Redistribution of EC-SOD Protects Against Sugen-Hypoxia Pulmonary Hypertension in Mice.

Pulmonary circulation·2026
Same author

Kernicterus Continues to Occur in the USA Despite Concerted Preventive Efforts.

Case reports in pediatrics·2026
Same journal

Congenital Blistering in a Newborn: Thinking Beyond Infection.

NeoReviews·2026
Same journal

An Unusual Cause of Recurrent Escherichia coli Meningitis in a Preterm Infant.

NeoReviews·2026
Same journal

Giant Omphalocele.

NeoReviews·2026
Same journal

A Pregnant Person Requiring Medical Intensive Care Unit Management of Asthma.

NeoReviews·2026
Same journal

How Would You Manage Fever in a Neonate Who Has Passed CCHD Screening?

NeoReviews·2026
Same journal

Neurodevelopmental Follow-Up of a Child With Parechovirus Meningitis: Parental Perspective and Physicians' Reflection.

NeoReviews·2026
関連記事をすべて見る
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 7, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.5K

治療成績向上のための血小板輸血の実践

Robert D Christensen1,2, Patricia Davenport3, Martha C Sola-Visner3

  • 1Division of Neonatology, Department of Pediatrics, University of Utah, Salt Lake City, Utah.

NeoReviews
|December 31, 2025
PubMed
まとめ
この要約は機械生成です。

新生児の血小板輸血は救命的となりうるが、リスクを伴う。エビデンスに基づいた輸血の実践と管理プログラムは、血小板療法を受ける重症児の予後を改善するために不可欠である。

キーワード:
新生児血小板輸血NICU血小板減少症輸血管理

さらに関連する動画

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.0K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

関連する実験動画

Last Updated: Jan 7, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.5K
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

14.0K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.3K

科学分野:

  • 新生児医学;血液学;小児集中治療

背景:

  • 血小板輸血は新生児集中治療室で一般的である。;有益である一方で、新生児の血小板輸血は重大なリスクを伴う。;リスクを理解し、疾患の病態生理の理解を深めるための研究が進行中である。

研究 の 目的:

  • 血小板輸血と新生児の有害事象との関連を明確にする。;複数の輸血を受けるリスクの高い新生児への認識を高める。;エビデンスに基づいた制限的な輸血の実践を促進する。

主な方法:

  • 前臨床および臨床研究のレビュー。;新生児輸血のリスクとベネフィットに関する既存の文献の分析。;リスクの高い患者集団の特定。

主要な成果:

  • 成人ドナーからの新生児血小板輸血は、用量依存的なリスクと関連している。;有害事象には、重度の出血、気管支肺異形成症、神経発達障害が含まれる。;制限的な輸血戦略はリスクを軽減する可能性がある。

結論:

  • 輸血管理プログラムは新生児の予後を改善する。;臨床医は新生児の血小板輸血に対してエビデンスに基づいた実践を適用すべきである。;新生児血小板減少症の新規治療法が調査中である。